Nightingale Appoints Marc Filion to the Board of Directors

Nightingale adds experienced healthcare and telecommunications leader, Marc Filion, as 7^th member of its Board of Directors

MARKHAM, ON, Feb. 27, 2012 /CNW/ - Nightingale Informatix Corporation (TSX-V: NGH) "Nightingale" or "Company", an application service provider (ASP) of electronic medical record (EMR) software and related services today announced that Marc Filion has been appointed to the Company's Board of Directors, effective immediately.

"We are pleased to welcome Marc to the Board," said David Atkins, Chairman of the Board of Nightingale. "He has extensive experience in the Canadian healthcare IT, finance and telecommunications sectors. From his past leadership positions at Emergis and TELUS, he will bring a wealth of additional industry insight and business acumen to the Board, which will be of great value as we embark on the Company's next phase of growth. In particular, Marc's experience growing and scaling BCE Emergis from a start-up to a leader in the Canadian healthcare technology market will be a key asset to Nightingale."

Mr. Filion has held many leadership positions in the Healthcare and technology industries, most recently, as COO of Telus Health. Prior to joining Telus, Mr. Filion was an instrumental member of the leadership team that started and grew BCE Emergis until its sale to Telus. Mr. Filion has more than 20 years of experience in business leadership, turnaround, strategy, sales, negotiation, partnership, mergers, acquisitions and divestitures. He is currently the President of a management consulting firm, Vision 360, which offers strategic growth and turnaround, negotiation, merger and acquisition consulting services to Canadian enterprises. Mr. Filion holds an MBA in Strategy and Marketing from UCLA Anderson School of Management and a BA in Marketing from HEC Montréal.

Nightingale's Board of Directors is now comprised of David Atkins, Chairman, David Banks, Director, Charles Frumberg, Director, Brian Schachter, Director, George Christodoulou, Director and Sam Chebib President, CEO and Director.

About Nightingale Informatix Corporation (www.nightingalemd.com)

Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) and patient portals, serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected.

Forward-Looking Statements

This news release includes certain forward-looking statements that are based upon current expectations, which involve risks and uncertainties associated with Nightingale's business and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts, but reflect Nightingale's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including the matters discussed under "Risks and Uncertainties" in the Filing Statement filed on November 29, 2011 with the regulatory authorities. Nightingale assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Investor Inquiries 
Kristen Dickson, M.Sc.
TMX Equicom
Tel: [phone] ext. 273
[email protected]